Áõ·Ê   Çлý¹ßÇ¥   °øÇØ   ¸é¿ªÄ¡·á   ÇÑÀÇÇп¡ ´ëÇÑ ³ªÀÇ ÀÌÇØ 
 
[¸ÞÀϸµ½Åû/Å»Åð]
  °íÁ¤°Ë»ö :  ¾Ë·¹¸£±â°³·Ð  /  ¾Ë·¹¸£°Õ  /  ±â°üÁöõ½Ä  /  ¾ÆÅäÇÇÇǺο°  /  À½½Ä¾Ë·¹¸£±â  /  µÎµå·¯±â  /  ¾Ë·¹¸£±âºñ¿° [ÃÖ½ÅÀÚ·á]
ÇöÀçÀ§Ä¡ : ¿¬±¸³ëÆ®
 
 Ãâ·Â    ¸ÞÀÏ    ¸®½ºÆ®    Ãßõ
Áõ·Ê 9. ¾ÆÅäÇÇÇǺο° - ³»¼º°ú ȸÇÇ

ÀÔ·ÂÀÏ:2009-01-28 / Á¶È¸¼ö:10672 / Ãßõ¼ö:631 / ÀÛ¼ºÀÚ:drmesh

2009³â 1¿ù 7ÀÏ È¯ÀÚ Áõ·Ê

3³â 11°³¿ùµÈ ¿©ÀÚȯÀÚ(À± **)°¡ ³»¿øÇÏ¿´´Ù. 

ȯÀÚ´Â °¡Á··Â»ó ¾Æ¹öÁö°¡ ºñ¿° ÀÖ°í ÇöÀç µ¿»ýÀÌ Ãµ½ÄÀ¸·Î °í»ýÇϰí ÀÖ´Ù.

°ú°Å·Â»ó ž¼­ 3ÁÖ ÈĺÎÅÍ ¸ö¿¡ ¾ÆÅäÇÇÇǺο°ÀÌ ¹ß»ýÇÏ¿´°í ÀÌÈÄ ´Ù¾çÇÑ º´¿øÀ» ´Ù´Ï¸é¼­ ´Ù¾çÇÑ Ä¡·áÇÏ¿´´Ù. º»¿ø¿¡ ³»¿øÇÑ °ÍÀº 2007³â 11¿ù ´ÞÀ̾ú´Ù. ÀÌ ´ç½Ã º»¿ø¿¡ ³»¿øÇϱâ Àü °Ë»ç¿¡¼­ ¶¥Äá°ú °è¶õÀº CAP¿¡¼­ 100 IU/L ÀÌ»ó ³ª¿Ô°í ¸Ô±â¸¸Çϸé õ½Ä ¹ßÀÛÀ» ÇÏ¿´À¸¸ç ±¹¼Ò ½ºÅ×·ÎÀ̵åÁ¦¿Í Ç× Áø±ÕÁ¦¸¦ »ç¿ëÇÏ¿´´Ù. ¸Ô´Â °Íµµ ´Ù¾çÇÏ°Ô Á¦ÇÑÀ» Çϰí ÀÖ¾ú´Ù.

¾ÆÅäÇÇÇǺο°Àº À¯ÁöÄ¡·áÇϸ鼭 õ½Ä Ä¡·á¸¦ ½ÃÇàÇÏ¿´°í ÀÌÈÄ 2008³â 2¿ù´Þ Ÿ º´¿ø¿¡¼­ ´Ù½Ã ¾Ë·¹¸£±â °Ë»ç¸¦ ÇÏ¿´°í ºñ½ÁÇÑ °á°ú¸¦ ¾ò¾ú´Ù.

2008³â ¿©¸§ºÎÅÍ Áõ¼¼ ¾ÆÅäÇÇÇǺο° ¾ÇÈ­µÇ¾î¼­ °æ±¸¿ë ½ºÅ×·ÎÀ̵带 Ÿ º´¿ø¿¡¼­ ½ÃÀÛÇÏ¿´°í ÀÌÈÄ Á¶Àý ÇÏ´Ù ²÷¾ú´Ù°í ÇÏ¿´´Ù.

2008³â 12¿ù´Þ ´Ù½Ã ½ÉÇØÁö¾î¼­ °æ±¸¿ë ½ºÅ×·ÎÀÌµå º¹¿ëÀ» Çϸ鼭 º»¿ø¿¡ ³»¿øÇÏ¿© ´ÙÀ½°ú °°Àº Áú¹®À» ÇÏ¿´´Ù.

1. ¿ìÀ¯¸¦ ²ú¿©¼­ ¸ÔÀ̸é ÁÁ´Ù´Âµ¥ ±¦ÂúÀºÁö ?

    ÀÌ·± ±Ã±ÝÁõÀº Ç׽à ÀÖ¾î¿Ô´Ù. ¾î¶² ½Äǰ¿¡ ¾Ë·¹¸£±â°¡ ÀÖÀ» ¶§ ÀÌ ½ÄǰÀ» °è¼Ó ¸Ô¿©¼­ ½Äǰ¿¡ ³»¼ºÀÌ »ý±â°Ô ÇÏ´Â°Ô ÁÁÀº°¡ ? ¾Æ´Ï¸é ¾Æ¿¹ ¸ÔÀÌÁö ¾Ê°í ±â´Ù¸®´Â °ÍÀÌ ÁÁÀº°¡ ?

    ÀÌÁ¦±îÁö´Â ¡°È¸ÇÇ¿ä¹ý¡±, Áï ¾È ¸ÔÀÌ°í ±â´Ù¸®´Â °ÍÀ» ÃßõÇÏ¿´Áö¸¸, ¸ÔÀ̸鼭 ¡®°ü¿ë¡¯À» À¯µµÇÏÀÚ´Â ÀǰßÀÌ ÃÖ±Ù Áõ°¡Çϰí ÀÖ´Ù. ÀÌÁ¦±îÁö ¸ÔÀ̸鼭 Ű¿ìÀÚ´Â ÀǰßÀÌ ÈûÀ» ¹ÞÁö ¸øÇÑ ÀÌÀ¯´Â ±×¿¡ ÇÕ´çÇÑ Áõ°ÅµéÀÌ ºÎÁ·ÇÏ¿´±â ¶§¹®ÀÌ´Ù.

    ÇÑ ¿¬±¸ÀÚ ±×·ìÀÌ ¸ÔÀ̸鼭 °ü¿ëÀ» À¯µµÇÏ´Â °ÍÀº ¾î¶²°¡ ÇÏ´Â ÀǰßÀ» Á¦½ÃÇÏ¿´´Ù1). 45¸íÀ» ´ë»óÀ¸·Î ¿¬±¸ÀÚµéÀº SOTI (specific oral tolerance induction) ¿¬±¸¸¦ ½ÃÇàÇÏ¿´´Ù. SOTI¶õ ¿ìÀ¯, ´Þ°¿¿¡ ¾Ë·¹¸£±â Áõ»óÀÌ Àִ ȯÀڵ鿡°Ô ¸ÅÀÏ Á¶±Ý¾¿ ´Ü¹éÁú ¿ë·®À» Áõ·®Çϸ鼭 ¸ÔÀÌ´Â °ÍÀÌ´Ù. Áï ¸ÔÀ̸鼭 °ü¿ë(tolerance)À» À¯µµÇÏ´Â °ÍÀÌ´Ù. ¿¬±¸±º 25¸í Áß 9¸íÀº °ü¿ëÀÌ »ý±â¾ú°í 3¸íÀº ÀÏ»óÀûÀ¸·Î ½ÄǰÀ» ¸ÔÀ» Á¤µµ·Î ÁÁ¾ÆÁö¾ú°í 4¸íÀº ºÎºÐÀûÀ¸·Î È£ÀüµÇ¾ú´Ù. ´ëÁ¶±º 20¸í Áß 7¸íÀÌ ÁÁ¾ÆÁö¾ú´Ù.

    ¿¬±¸ °á°ú¿¡ µû¸£¸é, ½Äǰ ¾Ë·¹¸£±â ȯÀÚ¿¡¼­ ȸÇǺ¸´Ù´Â ¸ÔÀÌ¸é ´õ µµ¿òÀÌ µÉ ¼ö ÀÖ´Ù. ¿©±â¼­ ÁÖÀÇÇÒ Á¡Àº ¡®°ü¿ë¡¯ÀÌ »ý±æ¸¸ÇÑ ¾ÆÀ̵鿡°Ô ½Ãµµ¸¦ ÇØ º¸¾Æ¾ß ÇÑ´Ù´Â Á¡ÀÌ´Ù. SOTI ¿¬±¸Àڵ鵵 ½ÉÇÑ ¾ÆÅäÇÇÇǺο° ȯÀÚµéÀº ¿¬±¸¿¡¼­ Á¦¿ÜÇÏ¿´´Ù.

    ¿ìÀ¯³ª ´Þ°¿À» ²ú¿©¼­ ¸é¿ª°ü¿ëÀ» À¯µµÇÑ ¿¬±¸°¡ ÃÖ±Ù¿¡ µÎ ÆíÀÌ ½Ç·È´Ù. Çϳª´Â ¿ìÀ¯À̰í Çϳª´Â ´Þ°¿ÀÌ´Ù.

    ÀÌ·¯ÇÑ ½ÇÇèÀº ÀϺ» ¿¬±¸ÀÚµéÀÌ ¸¹ÀÌ ÇÑ´Ù´Â À̾߱⸦ ´Ù¸¥ ¿¬±¸ÀÚ¸¦ ÅëÇØ µé¾ú´Âµ¥, Àß µðÀÚÀÎµÈ ¿¬±¸ °á°ú¸¦ ³» ³í °ÍÀº ¹Ì±¹ÀεéÀÌ´Ù.

    ¸ÕÀú ¿ìÀ¯¸¦ ²úÀÎ ¹æ¹ýÀº 150µµ ¿Àºì¿¡ 30ºÐ°£ ¿ìÀ¯ ´Ü¹éÁúÀ» ¸ÓÇÉ¿¡ ³Ö°í ²ú¿´´Ù. ´Ù¸¥ ÇÑ ¹æ¹ýÀº 260µµ ¿ÍÇñâ±â¿¡ ¿ìÀ¯ ´Ü¹éÁúÀ» ¿ÍÇÿ¡ ³Ö°í 3ºÐ°£ ²ú¿´´Ù. ¸ÕÀú ȯÀÚ¿¡°Ô ¸ÓÇÉÀ» ¸ÔÀÌ°í ±¦ÂúÀ¸¸é 2½Ã°£ ÈÄ ¿ÍÇÃÀ» ¸Ô¿´´Ù2).

    ÀÌ·¸°Ô ¿ìÀ¯¸¦ ¸ÔÀÌ´Ï ¿ìÀ¯ ¾Ë·¹¸£±â°¡ ÀÖ¾ú´ø ȯÀÚ 75%°¡ ¿ìÀ¯¸¦ ¸ÔÀ» ¼ö ÀÖ¾ú´Ù. Èï¹Ì·Î¿î ¿¬±¸°á°úÀÓ¿¡ Ʋ¸²¾ø´Ù. ¿ìÀ¯¸¦ ¸ÔÁö ¸øÇØ °í»ýÇÏ´Â ¾ÆÀ̵鿡°Ô ¸ÅÀÏ À¯¾÷¿¡¼­ ³ª¿Â ¿ÏÀü°¡¼öºÐÇØ ¿ìÀ¯ÀÎ HA ºÐÀ¯¸¦ ¸ÔÀ̵µ·Ï ±³À°Çϰí Àִµ¥ ²úÀÎ ¿ìÀ¯¸¦ ¸ÔÀÌ°í ±¦Âú¾ÒÀ¸´Ï ÁÁÀº ¿¬±¸ÀÓ¿¡ Ʋ¸²¾ø´Ù. ¿¬±¸°á°ú¸¦ º¸¸é ²úÀÎ ¿ìÀ¯¸¦ ¸Ô°í ¹ÝÀÀÀÌ ¾ø¾ú´ø ¾ÆÀ̵éÀº ²úÀÎ ¿ìÀ¯¸¦ ¸Ô°í ¹ÝÀÀÀ» º¸ÀÎ ¾ÆÀ̵麸´Ù IgE ¼öÄ¡°¡ ³·´Ù. Áï Áõ»óÀÌ ½ÉÇÏÁö ¾ÊÀº ¾ÆÀ̵éÀº ±×¸® ¸Ô¿©º¸´Â °Íµµ ÁÁ´Ù´Â À̾߱âÀÌ´Ù.

    ¿¬±¸ÀÚµéÀº IgE¼öÄ¡°¡ 5 kU/L À϶§ ¿ìÀ¯ ¾Ë·¹¸£±â°¡ ÀÖ´Â ¾ÆÀ̵鿡°Ô ¿ìÀ¯¸¦ ²ú¿© ¸ÔÀÌ´Â °ÍÀ» ½ÃµµÇغ¼ ¸¸ÇÏ´Ù°í ÇÏ¿´´Ù.

    ´Þ°¿¿¡¼­µµ °°Àº ¿¬±¸ÀÚ°¡ ºñ½ÁÇÑ ¿¬±¸µðÀÚÀÎÀ¸·Î ¿¬±¸°á°ú¸¦ ³»³õ¾Ò´Ù3). ´Þ°¿µµ ¶È°°ÀÌ ¿ìÀ¯¿Í °°Àº Á¶°ÇÀ¸·Î ¸¸µé¾î¼­ ¸Ô¿©º¸¾Ò´Ù.

    °á°ú´Â ¿ìÀ¯¿Í ºñ½ÁÇÏ¿´´Ù. ´ëºÎºÐ ²úÀÎ ´Þ°¿À» ¸Ô°í ¾Ë·¹¸£±â ¹ÝÀÀÀÌ ³ªÅ¸³ªÁö ¾Ê¾Ò´Ù. ¿ìÀ¯¿Í ¸¶Âù°¡Áö·Î ²úÀÎ ´Þ°¿¿¡ ¹ÝÀÀÇÏÁö ¾ÊÀº ¾ÆÀ̵éÀÌ IgE ¼öÄ¡°¡ ³·°í Àü¹ÝÀûÀ¸·Î Áõ»óµµ ÀÛÀº ¾ÆÀ̵éÀ̾ú´Ù.

    ÀÌ·¯ÇÑ ¿¬±¸¸¦ º¼ ¶§ ³ªÀÇ È¯ÀÚ¿¡¼­ ²úÀÎ ¿ìÀ¯³ª ´Þ°¿À» Çѹø ½ÃµµÇØ º¼ ¼ö´Â ÀÖÀ» °ÍÀÌ´Ù. ±×·¯³ª IgE ¼öÄ¡°¡ ³ô±â¿¡ ½ÇÆÐÇÒ °¡´É¼ºÀÌ ¸¹À» °ÍÀÌ´Ù.

 

2. ¿ì¸® ¾ÆÀÌ´Â ¿ìÀ¯, ´Þ°¿ ¾Ë·¹¸£±â°¡ ÁÁ¾ÆÁú±î ?

    ´Þ°¿ ¾Ë·¹¸£±â´Â Ãâ»ý ÈÄ 1-2% ¾ÆÀ̵éÀÌ °í»ýÇÏ°Ô µÈ´Ù. ¿ìÀ¯ ¾Ë·¹¸£±â ȯÀÚ´Â À̺¸´Ù Á¶±Ý ¸¹°í ¶¥ÄáÀº À̺¸´Ù Àû´Ù°í ¹Ì±¹ ¼Ò¾Æ°ú Ã¥¿¡´Â ¾²¿©ÀÖ´Ù. ³ªÀÇ °æÇèÀ¸·Î´Â ¿ì¸®³ª¶ó ¾ÆÀ̵éÀº ¿ìÀ¯º¸´Ù´Â ´Þ°¿ÀÌ ´õ ¸¹Áö ¾Ê³ª ¿©°ÜÁö´Âµ¥ ÀûÀýÇÑ µ¥ÀÌÅÍ´Â ±¸ÇÏÁö ¸øÇÏ¿´´Ù.

    ½Äǰ ¾Ë·¹¸£±âÀÇ ¿¹ÈÄ¿¡ ´ëÇØ¼­ ¼Ò¾Æ°ú Ã¥ÀÚ¿¡´Â ÀÌ·± ¹®±¸°¡ ÀÖ´Ù.

    ¡°¿ìÀ¯¿Í ´Þ°¿ ¾Ë·¹¸£±â´Â ¹ß»ýÇÑ Áö 2-3³âÀÌ Áö³ª¸é ȯÀÚÀÇ ¹Ý Á¤µµ°¡ ÁÁ¾ÆÁø´Ù¡±

    Áï ¾î¶² Ä¡·á¸¦ ÇÏÁö ¾Ê´õ¶óµµ Áõ»óÀÌ È£ÀüµÈ´Ù.

    ÇÑ ¿¬±¸ÀÚ°¡ 3Â÷ º´¿ø¿¡ ³»¿øÇÑ È¯ÀÚµéÀÇ ´Þ°¿ ¾Ë·¹¸£±â ¿¹Èĸ¦ ÃßÀûÇÏ¿© º¸¾Ò´Ù4).

    881¸íÀÇ È¯ÀÚ Áß 4¼¼¿¡ 4%, 6¼¼¿¡ 12%, 10¼¼¿¡ 37%, 16¼¼¿¡ 68%°¡ È£ÀüµÇ¾ú´Ù. »çÃá±â±îÁö ´Þ°¿ ¾Ë·¹¸£±â Áõ»óÀÌ ÁøÇàµÇ´Â ¾ÆÀ̵éÀº IgE¼öÄ¡°¡ ³ô¾Ò°í ´Ù¸¥ ½Äǰ¿¡µµ ¾Ë·¹¸£±â¹ÝÀÀÀÌ ÀÖ¾ú´Ù. ´Þ°¿ IgE ¼öÄ¡°¡ 50 kU/L ÀÌ»óÀ̸é Áö¼ÓµÉ °¡´É¼ºÀÌ ¸¹´Ù°í ¼³¸íÇÏ¿´´Ù.

    ÀÌ·¯ÇÑ ¿¬±¸°á°ú´Â Ã¥¿¡ ¾²¿©Áø °Íº¸´Ù ¿¹Èİ¡ ³ª»Ûµ¥, ½ÇÁ¦ ´Þ°¿ ¾Ë·¹¸£±â ¿¹Èİ¡ ³ª»Ú´Ù±âº¸´Ù´Â ȯÀÚ ´ë»óÀÌ 3Â÷ ÀÇ·á±â°üÀ̰í Áõ»óÀÌ È£ÀüµÈ ¾ÆÀ̵éÀϼö·Ï ÃßÀû Çϱâ Èûµé±â¿¡ ¿¹Èİ¡ ³ª»Ú°Ô ³ª¿Â °ÍÀÌ¶ó ¿©°ÜÁø´Ù.

    ¿ìÀ¯¿¡ ´ëÇØ¼­µµ ÇÑ ¿¬±¸ÀÚ°¡ ÃßÀûÇÑ ¿¬±¸¿¡ µû¸£¸é5),

    807¸í Áß 4¼¼¿¡ 19%, 8¼¼¿¡ 42%, 12¼¼¿¡ 64%, 16¼¼¿¡ 79% È£ÀüµÇ¾ú´Ù. ÀÌ ¼öÄ¡ ¶ÇÇÑ Ã¥¿¡ ¾º¿©Áø °Íº¸´Ù ³ôÀº ¼öÄ¡ÀÌ´Ù. ¿ìÀ¯ ¾Ë·¹¸£±â°¡ Áö¼ÓµÇ´Â ¾ÆÀ̵éÀÇ Æ¯Â¡Àº ±â°üÁö õ½ÄÀ̳ª ¾Ë·¹¸£±â ºñ¿°ÀÌ µ¿¹ÝµÇ¾úÀ» ¶§, IgE ¼öÄ¡°¡ ³ôÀ» ¶§ÀÌ´Ù.

    ¿ìÀ¯ ¾Ë·¹¸£±â ¿¹Èİ¡ ³ª»Û ¿¹ÃøÀÎÀڷδÂ6)

    2¼¼ ¶§ ¿ìÀ¯ IgE¼öÄ¡°¡ ³ô°í, À¯¹ß°Ë»ç¿¡¼­ µÎµå·¯±â Áõ»óÀÌ ¹ßÇöµÇ¾ú°Å³ª, Ãâ»ý Á÷ÈÄ ºÐÀ¯¸¦ ¼öÀ¯ÇÏ¿´°Å³ª, ´Þ°¿¿¡ Á¶±â °¨ÀÛÀÌ µÇ¾úÀ» ¶§ÀÌ´Ù.

    ÀÌ·¯ÇÑ °á°úµéÀ» º»´Ù¸é, º»¿ø¿¡ ³»¿øÇÑ ¾ÆÀÌ´Â IgE ¼öÄ¡°¡ 100 kU/LÀÌ»ó ³ô°í, ¾ÆÅäÇÇÇǺο°°ú ÇÔ²² õ½Äµµ µ¿¹ÝµÇ¾î Àֱ⿡ ¿¹ÈÄ´Â ³ª»Ü °ÍÀÌ¶ó ¿©°ÜÁø´Ù.

 

3. °æ±¸¿ë ½ºÅ×·ÎÀ̵å´Â ¾ó¸¶³ª ¸ÔÀ» ¼ö ÀÖ´ÂÁö ? ¾ðÁ¦ ²÷¾î¾ß ÇÏ´ÂÁö ?

    ¾ÆÅäÇÇÇǺο°ÀÌ ½ÉÇÑ È¯ÀÚ¿¡¼­ °æ±¸¿ë ½ºÅ×·ÎÀ̵åÁ¦¸¦ »ç¿ëÇÏ´Â °ÍÀÌ ÁÁÀº ¹æ¹ýÀÎÁö, ¾Æ´ÑÁö´Â ÀÇ°ß ÀÏÄ¡¸¦ º¸±â´Â ¾î·Á¿ï °ÍÀÌ´Ù.

    ±×·¯³ª Àü½Å ½ºÅ×·ÎÀ̵带 ¾²°í ³ª¼­ ¹Ýµ¿Çö»ó(rebound phenomenon)À» °í·ÁÇÑ´Ù¸é »ç¿ë¿¡ ¸Å¿ì ½ÅÁßÇØ¾ß ÇÔÀº Ʋ¸²¾ø´Ù.

    Àü½Å ½ºÅ×·ÎÀ̵带 »ç¿ëÇÏ°í ½Í´Ù¸é ¸ÕÀú ª°Ô ½á¾ßÇϰí, ²÷´Â °ÍÀ» õõÈ÷ Çϸ鼭 ±¹¼Ò ½ºÅ×·ÎÀ̵å¿Í ´Ù¸¥ Ä¡·á¸¦ º´ÇàÇØ¾ß ÇÑ´Ù7).

 

4. ´Ù¸¥ º´¿ø¿¡¼­ È÷½ºÅäºÒ¸°À» »ç¿ëÇϴµ¥ ¾ÆÅäÇÇÇǺο°¿¡ È¿°ú°¡ ÀÖ´ÂÁö ?

    È÷½ºÅäºÒ¸°À̶õ ³ì½ÊÀÚ¿¡¼­ ³ª¿À´Â ¾àÁ¦·Î È÷½ºÅ¸¹Î 0.15 ug°ú ¸é¿ª±Û·ÎºÒ¸° IgG 12 mgÀÌ µéÀº ¾àǰÀÌ´Ù. ³ªÀÇ ¼±»ý´ÔÀÌ ÁÁ¾ÆÇϽô ¾àÁ¦Àε¥, Àü°øÀÇ ¶§ °üÂûÇÑ ¹Ù·Î´Â ¸¸¼º ±âħ¿¡´Â È¿°ú°¡ ÀÖÁö¸¸ ¾ÆÅäÇÇÇǺο°¿¡´Â µµ¿òÀÌ ¾ÈµÇ´Â °Í °°Àº ´À³¦À» ¹Þ¾Ò´Ù.

    ÀÌ·¯ÇÑ ¾àÁ¦¸¦ »ç¿ëÇϸé Ç׽à ġ·á È¿°ú Áõ°Å°¡ ÀÖ´À³Ä´Â Áú¹®À» ¹Þ°Ô µÈ´Ù. ¹°·Ð ¿¬±¸µÈ °ÍÀÌ ¾øÀ¸¹Ç·Î Áõ°Å°¡ ¾ø´Ù¶ó°í ¸»ÇÑ´Ù. Áõ°Å°¡ ¾ø´Ù ¶ó´Â °ÍÀÌ Ä¡·áÈ¿°ú°¡ ¾ø´Ù¶ó´Â ¸»Àº ¾Æ´Ï¹Ç·Î ¸¹Àº ¼±»ý´ÔµéÀÌ ¾ÆÁ÷ »ç¿ëÇϰí ÀÖ´Ù.

    ¾ÆÅäÇÇÇǺο°¿¡¼­ ¸é¿ª±Û·ÎºÒ¸°À» ¿ë·®À» ¸¹ÀÌ Á־ È¿°ú ¿©ºÎ¸¦ È®ÀÎÇϰí ÀÚ ÇÏ´Â ¿¬±¸µéÀÌ ÀÖ¾î¿Ô°í Ç׽à °á°ú´Â ¸íÈ®ÇÏÁö ¾Ê´Ù8, 9). ´ë¿ë·® ¸é¿ª±Û·ÎºÒ¸°À» Åõ¿©ÇÏ¿©µµ ¾ÆÅäÇÇÇǺο° È¿°ú ¿©ºÎ°¡ ºÒºÐ¸íÇÑ »óÅ¿¡¼­ È÷½ºÅäºÒ¸°ÀÇ ÀûÀº ¸é¿ª±Û·ÎºÒ¸°À¸·Î ¾ÆÅäÇÇÇǺο°¿¡ È¿°ú°¡ ÀÖÀ» °Í °°Áö´Â ¾Ê´Ù.

    ±×·¯¹Ç·Î ³ªÀÇ °æÇè°ú Áõ°Å ºÎÁ·À¸·Î ±×¸® ÃßõÇÒ ¸¸ÇÑ ¾àÁ¦´Â ¾Æ´Ï¶ó°í ¿©°ÜÁø´Ù.

 

5. ½Ì±Ö·¹¾î´Â ¾ÆÅäÇÇÇǺο°¿¡ µµ¿òÀÌ µÇ´ÂÁö ?

    ¸Ç óÀ½ ½Ì±Ö·¹¾î¿Í ¿À³íÀÌ ³ª¿ÔÀ» ¶§ ³ª´Â ÀÌ·¯ÇÑ ¾àÁ¦°¡ ±â°üÁö õ½Ä, ¾Ë·¹¸£±â ºñ¿° ¸¸ÀÌ ¾Æ´Ï¶ó ¸¸¼º µÎµå·¯±â, ¾ÆÅäÇÇÇǺο°°ú °¨±â Ä¡·á¿¡µµ ³Î¸® »ç¿ëµÉ °ÍÀ̶ó°í ¸»ÇÑ ÀûÀÌ ÀÖ¾ú´Ù. (·ùÄÚÆ®¸®¿£ ±æÇ×Á¦°¡ ¾ÆÅäÇÇÇǺο°¿¡ È¿°ú°¡ ÀÖÀ»±î ?)

    ±×µ¿¾È ¸î³âÀ̶ó´Â ¼¼¿ùÀÌ Èê·¶±â¿¡ ÀÌÁ¦±îÁö ¿¬±¸ ÁøÇàµÈ °ÍÀ» °ËÅäÇØ º¸ÀÚ. ±×µ¿¾È ³ªÀÇ °æÇè¿¡ µû¸£¸é, ¾ÆÅäÇÇÇǺο° Ä¡·áÁ¦·Î ½Ì±Ö·¹¾î³ª ¿À³íÀº ±×¸® Å« È¿°ú°¡ ¾ø´Ù.

    2¼¼¿¡¼­ 16¼¼ 25¸íÀÇ È¯ÀÚ¿¡¼­ È¿°ú°¡ ÀÖ´Ù´Â ÃֽŠ³í¹®10), 16¼¼ ÀÌ»ó ¼ºÀο¡¼­ ¾ÆÅäÇÇÇǺο°¿¡ Å« µµ¿òÀÌ ¾ÈµÇ¾ú´Ù´Â ³í¹®11), 59¸íÀÇ ¾ÆÅäÇÇÇǺο°È¯ÀÚ¿¡¼­ È¿°ú°¡ ¼ºÀο¡¼­ ¾ø¾ú´Ù´Â ³í¹®12)ÀÌ ÀÖ´Ù.

    ÀÌ·¯ÇÑ ¿¬±¸°á°ú¿Í ³ªÀÇ °æÇèÀ» º»´Ù¸é ¾ÆÅäÇÇÇǺο°¿¡ ½Ì±Ö·¹¾î³ª ¿À³íÀº ÃßõµÉ ¾àÀÌ ¾Æ´Ñ °ÍÀ¸·Î ¿©°ÜÁø´Ù. Ȥ½Ã Á¶±Ý µµ¿òÀÌ µÇ´Â ȯÀÚµéÀº ÀÖÀ» ¼ö ÀÖÀ¸³ª ±¤¹üÀ§ÇÏ°Ô ÃßõÇÏ¿© Ä¡·áÈ¿°ú¸¦ º¼ ¼ö ÀÖÀ» °Í °°Áö´Â ¾Ê´Ù.

    ±×·¯¹Ç·Î ½Ì±Ö·¹¾î¿Í ¿À³í ¾àÁ¦ÀÇ È¿´É¿¡ ´ëÇØ¼­ ¾ÆÅäÇÇÇǺο°Àº È¿°ú°¡ ¾ø´Ù¶ó°í ¸»ÇÏ°í ½Í´Ù.

 

6. Âü°í¹®Çå

1) Allergy. 2007 Nov;62(11):1261-9. Specific oral tolerance induction in food allergy in children: efficacy and clinical patterns of reaction. Staden U, Rolinck-Werninghaus C, Brewe F, Wahn U, Niggemann B, Beyer K. Department of Pediatric Pneumology and Immunology, University Children's Hospital Charité, Berlin, Germany.

2) J Allergy Clin Immunol. 2008 Aug;122(2):342-7, 347.e1-2. Tolerance to extensively heated milk in children with cow's milk allergy. Nowak-Wegrzyn A, Bloom KA, Sicherer SH, Shreffler WG, Noone S, Wanich N, Sampson HA. Department of Pediatrics and Jaffe Food Allergy Institute, Mount Sinai School of Medicine, New York, NY 10029, USA. anna.nowak-wegrzyn@mssm.edu

3) J Allergy Clin Immunol. 2008 Nov;122(5):977-983.e1. Immunologic changes in children with egg allergy ingesting extensively heated egg. Lemon-Mulé H, Sampson HA, Sicherer SH, Shreffler WG, Noone S, Nowak-Wegrzyn A. Department of Pediatrics, Jaffe Food Allergy Institute, Mount Sinai School of Medicine, New York, NY 10029, USA.

4) J Allergy Clin Immunol. 2007 Dec;120(6):1413-7. The natural history of egg allergy. Savage JH, Matsui EC, Skripak JM, Wood RA. Department of Pediatrics, Division of Allergy and Immunology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

5) J Allergy Clin Immunol. 2007 Nov;120(5):1172-7. The natural history of IgE-mediated cow's milk allergy. Skripak JM, Matsui EC, Mudd K, Wood RA. Department of Pediatrics, Division of Allergy and Immunology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

6) J Allergy Clin Immunol. 2005 Oct;116(4):869-75. Clinical course and prognosis of cow's milk allergy are dependent on milk-specific IgE status. Saarinen KM, Pelkonen AS, Mäkelä MJ, Savilahti E. From Hospital for Children and Adolescents, University of Helsinki, Finland.

7) Ann Allergy Asthma Immunol. 2004 Sep;93(3 Suppl 2):S1-21. Disease management of atopic dermatitis: an updated practice parameter. Joint Task Force on Practice Parameters.Leung DY, Nicklas RA, Li JT, Bernstein IL, Blessing-Moore J, Boguniewicz M, Chapman JA, Khan DA, Lang D, Lee RE, Portnoy JM, Schuller DE, Spector SL, Tilles SA. Division of Pediatric Allergy-Immunology, Department of Pediatrics, National Jewish Medical and Research Center and University of Colorado Health Sciences Center, Denver, Colorado, USA. ¿ø¹®º¸±â

8) Acta Derm Venereol. 2003;83(6):433-7. Adjunctive high-dose intravenous immunoglobulin treatment for resistant atopic dermatitis: efficacy and effects on intracellular cytokine levels and CD4 counts. Jolles S, Sewell C, Webster D, Ryan A, Heelan B, Waite A, Rustin M. National Institute for Medical Research, Division of Infection and Immunity, The Ridgeway, Mill Hill, London, UK. sjolles@nimr.mrc.ac.uk

9) Br J Dermatol. 2002 Sep;147(3):518-22. A randomized controlled evaluator-blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis. Paul C, Lahfa M, Bachelez H, Chevret S, Dubertret L. Department of Dermatology, Saint Louis University Hospital, 1 avenue Claude Vellefaux, 75475 Paris, France.

10) Eur Ann Allergy Clin Immunol. 2007 Sep;39(7):232-6. Montelukast treatment in children with moderately severe atopic dermatitis. Ehlayel MS, Bener A, Sabbah A. Department of Pediatrics Allergy and Immunology, Hamad Medical Corporation.

11) Clin Exp Allergy. 2007 Oct;37(10):1536-40. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema. Friedmann PS, Palmer R, Tan E, Ogboli M, Barclay G, Hotchkiss K, Berth-Jones J. Department of Dermatology, Southampton General Hospital, Southampton, Hampshire, UK.

12) J Am Acad Dermatol. 2005 Jul;53(1):147-9. Montelukast treatment of moderate to severe atopic dermatitis in adults: a randomized, double-blind, placebo-controlled trial. Veien NK, Busch-S©ªrensen M, Stausb©ªl-Gr©ªn B. Dermatology Clinic, Aalborg, Denmark. veien@dadlnet.dk

 

 
100ÀÚÆò ¾²±â  À̸§: ÀÔ·ÂÀÏ:2022-06-27 
 
ÀÛ¼ºÀÚ : RoyalCBD
91q1C6 Maybe in the future it all do even better in those areas, but for now it as a fantastic way to organize and listen to your music and videos,
ÀÛ¼ºÀÚ : pron best
INdogA Very good information. Lucky me I found your website by accident (stumbleupon). I ave book-marked it for later!
ÀÛ¼ºÀÚ : pron best
5Mtcqe Major thankies for the blog article.Thanks Again. Want more.
ÀÛ¼ºÀÚ : Get the facts
9IDDJj Really enjoyed this post.Really thank you! Keep writing.
ÀÛ¼ºÀÚ : lananal
cIQg8R Link exchange is nothing else except it is simply placing the other person as blog link on your page at suitable place and other person will also do similar for you.|
ÀÛ¼ºÀÚ : big dilbos
LTUcmg I will bookmark your weblog and take a look at again right here regularly.
ÀÛ¼ºÀÚ : porn movies
p4WjsU THE HOLY INNOCENTS. cherish the day ,
ÀÛ¼ºÀÚ : big dildos
Some really choice posts on this internet site , saved to fav.
ÀÛ¼ºÀÚ : mark photo
fhiTjQ Thanks again for the article post. Really Great.
ÀÛ¼ºÀÚ : coco service fiverr
OepdY7 whoah this blog is wonderful i love reading your articles. Keep up the good work! You know, many people are hunting around for this information, you can aid them greatly.
ÀÛ¼ºÀÚ : cocoservice on fiver
UW205S This website was how do you say it? Relevant!! Finally I have found something which helped me. Thank you!
ÀÛ¼ºÀÚ : BcWTWBPZFv
OJS7pL
ÀÛ¼ºÀÚ : fiverr crork
1bV4ab I am so grateful for your article.Really thank you! Cool.
ÀÛ¼ºÀÚ : crork backlinks
2FU2Ql Major thanks for the article.Much thanks again. Great.
ÀÛ¼ºÀÚ : crork backlinks
24FfaX Very informative blog article.Really thank you! Really Great.
ÀÛ¼ºÀÚ : seo servicess
L1MilR Really appreciate you sharing this article.Really thank you! Fantastic.
ÀÛ¼ºÀÚ : seo service
1h2LGA I truly appreciate this post.Really looking forward to read more. Great.
ÀÛ¼ºÀÚ : crorkzz com
zGBIk4 Muchos Gracias for your article. Keep writing.
ÀÛ¼ºÀÚ : crork matt
QAODfz It's actually a cool and useful piece of information. I'm glad that you shared this useful info with us. Please keep us informed like this. Thanks for sharing.
ÀÛ¼ºÀÚ : baxz crorkzz
Y9UevW Thank you for another magnificent article. Where else could anybody get that type of info in such a perfect way of writing? I've a presentation next week, and I'm on the look for such information.
ÀÛ¼ºÀÚ : cheap backlinks
4FfO7z Im thankful for the blog post.Really thank you! Keep writing.
ÀÛ¼ºÀÚ : Razakzaidan
That's a slick answer to a chnglealing question
ÀÛ¼ºÀÚ : Sofiia
You've mangaed a first class post
ÀÛ¼ºÀÚ : Marling
This intaimofron is off the hizool!
ÀÛ¼ºÀÚ : Krystalyn
Stands back from the kyebaord in amazement! Thanks!
ÀÛ¼ºÀÚ : Judith
Artilces like this make life so much simpler.
ÀÛ¼ºÀÚ : Carlie
I have been so bweirldeed in the past but now it all makes sense!
 
 
°íÁ¤°Ë»ö :  ¾Ë·¹¸£±â°³·Ð  /  ¾Ë·¹¸£°Õ  /  ±â°üÁöõ½Ä  /  ¾ÆÅäÇÇÇǺο°  /  À½½Ä¾Ë·¹¸£±â  /  µÎµå·¯±â  /  ¾Ë·¹¸£±âºñ¿°  
Á¤º¸Á¦°ø¿øÄ¢¤ÓÁ¤º¸°øÀ¯¹æ¿î¿µ¿øÄ¢¤ÓÀúÀ۱ǰü·Ã¤Ó°³ÀÎÁ¤º¸º¸È£¿øÄ¢¤ÓÀ̸ÞÀϹ«´Ü¼öÁý°ÅºÎ¤Ó°íÁ¤ÇÊÁø±¸ÇÔ¤ÓºñÁ¯°ú »ç¸í
¸ðµç ±ÛÀº ÀúÀÛ±Ç ¹ýÀÇ º¸È£¸¦ ¹Þ´Â ¹Ù ¹«´Ü ÀüÀç. º¹»ç. ¹èÆ÷µîÀ» ±ÝÇÕ´Ï´Ù.